Skip to content

To evaluate the effect of Panchabhoutika Ghrita and Panchabhoutika tail Pratimarsha Nasya in Autistic children

Randomized comparative parallel clinical study on efficacy of both Panchabhoutika Ghrita and Panchabhoutika Taila Pratimarsha Nasya in the management of Autism in children

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041205
Enrollment
30
Registered
2022-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Panchabhoutika ghrita: In the form of Pratimarsha Nasya Intervention2: Panchabhoutika taila: In the form of Pratimarsha Nasya Intervention3: Panchabhoutika Ghrita: 2 drops of Panchabhou

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) Children between the age group of 5-12years diagnosed with Autism as per DSM-5 criteria are included irrespective of gender, religion and socio-economic status. (b) Child with Mild to moderate Autism according to CARS scale will be included.

Exclusion criteria

Exclusion criteria: (a) Children below 5years and above 12 years will be excluded. (b) Children with severe autism according to CARS scale will be excluded. (c) Children associated with co-morbidity like anxiety, depression, obsessive-compulsive disorder, seizures epilepsy etc., will be excluded. (d) Children associated with any other systemic illnesses will be excluded.

Design outcomes

Primary

MeasureTime frame
15 Components of CARS scale for Autism assessment will be assessed.Timepoint: 1st Follow up- 30th day. 2nd Follow up- 45th day. 3rd Follow up-60th day

Secondary

MeasureTime frame
Reduction in the CARS 1 ScoreTimepoint: 60 days

Countries

India

Contacts

Public ContactDr Karunya J G

Sri Sri College of Ayurvedic Science and Research Hospital

sudheerbrao@yahoo.co.in9900175777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026